ID   NCC-PS2-C1
AC   CVCL_E8VU
RX   PubMed=40253665;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Doubling time: 51 hours (PubMed=40253665).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=40253665
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 10,11
ST   D21S11: 30,31
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=40253665; DOI=10.1007/s13577-025-01217-8;
RA   Iwata, Shuhei
RA   Noguchi, Rei
RA   Osaki, Julia
RA   Adachi, Yuki
RA   Shiota, Yomogi
RA   Osaki, Shuhei
RA   Nishino, Shogo
RA   Yoshida, Akihiko
RA   Ohtori, Seiji
RA   Kawai, Akira
RA   Kondo, Tadashi
RT   "Establishment and characterization of NCC-PS2-C1: a novel cell line
RT   of high-grade pleomorphic spindle cell sarcoma, most consistent with
RT   myxofibrosarcoma.";
RL   Hum. Cell 38:93.1-93.10(2025).
//